Thursday, February 22, 2018
 
 
Company News: Page (1) of 1 - 02/14/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
US Drug Watchdog Now Appeals to a Person Who Used the Type Two Diabetes Drug Invokana and Suffered a Below the Knee Amputation to Call Them About Possible Significant Compensation
 
(February 14, 2018)

WASHINGTON, Feb. 14, 2018 /PRNewswire/ -- The US Drug Watchdog fears that some users of the type two diabetes drug called Invokana may have suffered a below the knee amputation without ever knowing there could be a connection between this diabetes drug and the loss of their lower leg. The group is appealing to a person who had a below the knee amputation after using the type two diabetes drug Invokana, to call them anytime at 866-714-6466. The group is also urging the family or friend of a diabetic who had a below the knee amputation to ask the person if they were using Invokana.

The US Drug Watchdog wants to ensure a person who may have been harmed by the type two diabetes drug Invokana has access to very skilled lawyers for a free legal consultation. For those people who suffered a below the knee amputation the financial compensation could be significant as they would like to explain anytime at 866-714-6466. http://USDrugWatchdog.Com

Possible Medical Side Effects Associated with Invokana:



  • BELOW-THE-KNEE AMPUTATIONS
  • KIDNEY FAILURE

The US Drug Watchdog says, "Our biggest worry about people who suffered a severe side effect from a recalled drugs or a potentially dangerous  pharmaceutical product is it is extremely difficult to identify actual victims. Diabetics are frequently told that diabetes could cause loss of feet or legs by medical doctors. Will a diabetic who was using the type two diabetes drug Invokana who had to suffer through a below the knee amputation instantly think-it was a drug that caused this-probably not. 

"We are urging the family or a friend of a diabetic who was using the type two diabetes drug Invokana and who suffered a below the knee amputation to call us anytime at 866-714-6466 so we can help get them to some of the nation's top lawyers for free legal consultation. Because it is so difficult to get the word out about potentially dangerous drugs for diabetics, the US Drug Watchdog is urging people with diabetes or their family members to post this press release on their Facebook page or social media." http://USDrugWatchdog.Com

In May 2017 the U.S. Food and Drug Administration issued what's called a black box warning about Invokana and amputations.In the warning the FDA urged patients taking canagliflozin, sold under the brand name Invokana, Invokamet and Invokamet XR, to contact their doctors "right away" if they notice pain or tenderness, sores, ulcers or infections in their legs or feet.  https://www.medscape.com/viewarticle/883782.

For more information about the type two diabetes drug called Invokana and severe side effects, please call the US Drug Watchdog anytime at 866-714-6466. http://USDrugWatchdog.Com

Invokana Case Number:(MDL) No. 2750 in New Jersey

Contact:

Thomas Martin

866-714-6466

[email protected]

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/us-drug-watchdog-now-appeals-to-a-person-who-used-the-type-two-diabetes-drug-invokana-and-suffered-a-below-the-knee-amputation-to-call-them-about-possible-significant-compensation-300598104.html

SOURCE US Drug Watchdog

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA,Family,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • SourceLink Partners with MassMedia Health to Provide Medicare Age-In Data to Healthcare Groups
  • Driven by Boomers, Consumer-Driven Genetic Testing Forecasted to Reach $310 Million
  • Global Mobile Medical Apps Market to Reach $11.22 Billion by 2025, Reports BIS Research
  • U.S. Nebulizer Market Size Worth $435.5 Million By 2025 | CAGR 6.2%: Grand View Research, Inc.
  • Global Cables and Leads for Medical Equipment Industry

    Cancer
  • argenx to host conference call & webcast to report fourth quarter business update and full year 2017 financial results on March 1, 2018
  • CytRx Announces the Presentation of New LADR™ Candidate Data at the American Association for Cancer Research 2018 Annual Meeting
  • Varian Acquires Evinance Innovation, Inc.
  • QCCA Evolves to Become the First National Clinically Integrated Network in Oncology
  • COA: Analysis Shows Virginia Hospitals Benefit From Recent Changes In Medicare Payment
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines